What Is the Treatment of Chronic Eosinophilic Pneumonia?
Chronic eosinophilic pneumonia requires a timely and structured treatment approach. The primary clinical priority is inducing remission and achieving resolution of pulmonary infiltrates while reducing the risk of relapse.
Treatment Approach
The mainstay of management is oral corticosteroid therapy, aimed at inducing remission and lowering relapse risk. The treatment course is tailored to individual clinical and radiological response, and duration varies considerably between patients.
Full agent selection, dosing strategy, tapering schedule, and duration guidance are available in the complete protocol below.
Treatment Goals
- Clinical improvement
- Resolution of pulmonary infiltrates on imaging
- Response typically expected within a few days of initiating therapy
- Induction of remission with reduced likelihood of relapse
References
DOI: 10.2147/TCRM.S157882
- The mainstay of treatment is based on oral corticosteroid (OCS) therapy, with a goal of inducing remission as well as reducing the possibility of relapse.
- Initial treatment is typically oral prednisone dosed at 0.5–0.6 mg/kg/day with the dose tapering off by one-half after confirmation of both clinical and radiologic resolution.
- A review of the current literature regarding treatment by Suzuki et al suggests that a starting dose of prednisolone around 30 mg would be adequate.
- Treatment periods are variable from a few months to 12 months depending on the clinical response.
- Response to OCS is usually dramatic and fairly rapid, with both clinical improvement and resolution of infiltrates on imaging.
- Of note, response typically occurs within a few days, and if rapid clinical improvement is not seen, alternative diagnoses should be reconsidered.
View source ↗